- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02842593
Vascular Responses to High vs Low Repetition Resistance Exercise Training in Young Men
January 13, 2017 updated by: Stuart Phillips, McMaster University
This study evaluates the effects of two types of resistance exercise training (higher-repetition, lower load vs lower-repetition, higher load vs control) on regional and local measures of arterial stiffness in trained young men.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8S4L8
- McMaster University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Male
- Aged 18-30 years old
- Non-obese (Body mass index less than 30 kg/m2)
- Non-smoker
- Healthy based on questionnaire responses
- Resistance trained (Resistance training > 2 times per week for 2 years, minimum 1 lower body exercise session per week)
Exclusion Criteria:
- Allergies to milk proteins (whey or casein)
- Any acute or chronic illness, cardiac, pulmonary, liver, or kidney abnormalities, uncontrolled hypertension, insulin- or non-insulin dependent diabetes or other metabolic disorders-all ascertained through medical history screening questionnaires
- Arthritic conditions
- Individuals who consume any analgesic or anti-inflammatory drug(s), prescription or non- prescription, chronically will be excluded
- A history of neuromuscular problems
- Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Resistance exercise training
Whole-body resistance exercise training 4x/week for 12 weeks.
Either 'lower-repetition, heavier-load' or 'higher-repetition, lighter-load' intervention.
|
8-12 reps/set at ~80% 1 repetition maximum
20-25 reps/set at ~30% 1 repetition maximum
|
|
No Intervention: Non-exercising control
Continue habitual physical activity for 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Carotid-femoral pulse wave velocity
Time Frame: 12 weeks post exercise training
|
Assessed using applanation tonometry
|
12 weeks post exercise training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Common carotid artery distensibility
Time Frame: 12 weeks post exercise training
|
Assessed using vascular ultrasound
|
12 weeks post exercise training
|
|
Left ventricular mass
Time Frame: 12 weeks post exercise training
|
Assessed using standard echocardiography
|
12 weeks post exercise training
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
August 1, 2016
Study Completion (Actual)
August 1, 2016
Study Registration Dates
First Submitted
July 15, 2016
First Submitted That Met QC Criteria
July 20, 2016
First Posted (Estimate)
July 25, 2016
Study Record Updates
Last Update Posted (Estimate)
January 16, 2017
Last Update Submitted That Met QC Criteria
January 13, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- REB 14-333-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.